Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/REGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Regeneron Pharmaceuticals Inc (REGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $735.2, up 0.05% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent news highlights a major $8 billion immunology alliance expansion with Sanofi, providing significant upfront and milestone payments. Valuation ratios appear reasonable with a P/E of 18.19 and net income margin of 27.86% for 2025. Cash flow improved in 2025 with net cash flow of $634.7 million.
The outlook is supported by robust profitability and strategic collaborations, but near-term price action faces resistance near $737. Risks include competitive pressures in key drug markets and reliance on successful clinical trials. Analyst consensus is strongly bullish with a $844.26 price target, suggesting potential upside from current levels if execution continues.
Read full analysis

Key Stats

  • Market Cap
    $79.75B
  • Volume
    612,910
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $557.73
  • Typical Hold Time
    107 Days
  • Enterprise Value
    $74.46B
  • Div Yield
    0.51%
  • Trading Activity
    -
$732.18
52W Low: $557.73
13 Oct 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $557.73 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Most Recent News

Content is generated by Aura AI

US Treasury yields top 5%, raising debt spiral fears but no fiscal crisis yet.

US Treasury yields have risen above 5%, sparking concerns about a potential debt spiral where rising interest costs force more borrowing. However, experts say a fiscal crisis is not imminent because the US economy's strong growth helps keep debt mana...

Market News
5 hours ago
CNBC
Neutral
US Treasury yields top 5%, raising debt spiral fears but no fiscal crisis yet.

Aroa Biosurgery's Symphony significantly improves diabetic foot ulcer healing in US trial.

Aroa Biosurgery reported positive results from a US clinical trial showing its Symphony wound care product improved healing outcomes for diabetic foot ulcers. In a study of 143 patients across 10 US sites, 55% of ulcers treated with Symphony plus sta...

Market News
6 hours ago
Proactive Investors
Bullish
news icon
Aroa Biosurgery's Symphony significantly improves diabetic foot ulcer healing in US trial.

Trump warns South Korea to join $50B Alaska LNG project or face higher costs, amid investment deal confusion.

U.S. President Donald Trump warned South Korea to sign on soon to the $50 billion Alaska LNG project or face higher charges, possibly tariffs, though he did not specify details. South Korea is still evaluating the project based on commercial viabilit...

Market News
6 hours ago
CNBC
Neutral
Trump warns South Korea to join $50B Alaska LNG project or face higher costs, amid investment deal confusion.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $79.75B
  • Volume
    612,910
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $557.73
  • Typical Hold Time
    107 Days
  • Enterprise Value
    $74.46B
  • Div Yield
    0.51%
  • Trading Activity
    -
$732.18
52W Low: $557.73
13 Oct 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $557.73 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!